Colorado Biosimilar Bill Passes a Key Hurdle

One week after a bill that would have made it more difficult to allow substitution of biosimilars stalled in the Mississippi legislature, a similar bill was passed by an overwhelming majority of a Colorado committee.
Pharmalot